What's New

CE Education
Improving the Spectrum of Care for Patients with Diffuse Large B-cell Lymphoma
James O. Armitage, MD; John P. Leonard, MD; and Jason Westin, MD, MS, FACP

Newsletter
Prophylaxis as a New Strategy for the Management of Patients with VWD
Miguel A. Escobar, MD

CE Education
New Directions in the Frontline Treatment of DLBCL: Implications for Practice
James O. Armitage, MD; and Andrew D. Zelenetz, MD, PhD

CE Education
New Directions in the Treatment of Relapsed/Refractory DLBCL: Implications for Practice
James O. Armitage, MD; and Matthew Lunning, DO, FACP

LIVE Webinar
Latest Advances in Gene Therapy for Hemophilia: An Integrated Care Model to Improve Outcomes
Register Now!

Newsletter
Recognizing and Treating von Willebrand's Disease in Women
Miguel A. Escobar, MD

CE Education
Current and Emerging Directions in the Frontline Treatment of Follicular Lymphoma: Implications for Practice
James O. Armitage, MD; and Gilles Salles, MD, PhD

CE Education
Prophylaxis in Patients with Von Willebrand Disease: Expert Perspectives and Shared Experiences
Robert F. Sidonio, Jr., MD, Miguel A. Escobar, MD, Angela C. Weyand, MD

CE Education
Addressing Disparities in Care for Patients with DLBCL
James O. Armitage, MD; and Loretta J. Nastoupil, MD

CE Education
Developments in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
Elizabeth Griffiths, MD, and Ilene C. Weitz, MD

Newsletters
Emerging Gene Therapies and Targeted Agents for Patients with Hemophilia
Steven W. Pipe, MD

© 2022 MediCom Worldwide, Inc. All rights reserved